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ABSTRACT 
 
REGULATION OF HUMAN p53 TUMOR SUPPRESSOR GENE 
ACTIVITY BY THIOL-DEPENDENT OXIDOREDUCTASES 
 
Background: Occurrence of p53 mutations in more than half of human tumors 
indicates the importance of p53 gene in cancer prevention. Nevertheless, oxidation of 
cysteine –SH groups in p53 protein can inactivate the protein under oxidative 
conditions. The importance of p53 as a tumor suppressor and insufficient studies about 
redox regulation of p53 gene lead us to study redox regulation of p53 protein. Methods: 
In this study, yeast (Saccharomyces cerevisiae) was used as an in vivo model. All 
potential thiol-dependent antioxidant genes in yeast were identified based on specific 
characters in their structure, via REDOXCysSearch bioinformatics tool. To study 
human p53 gene activity in yeast cells, p53 gene and p53 RE Lac-Z reporter that is 
inducible by p53, were transformed into yeast. Antioxidant gene mutants were analyzed 
for LacZ reporter gene activity. Results: We identified several yeast mutants (∆sac1, 
∆hnt3 and ∆map1) with lower p53 activity with respect to wild-type yeast. Conclusion: 
Due to conserved mechanisms of cell cycle regulation and oxidative stress tolerance 
between yeast and mammals, we believe that results from yeast studies may help us to 
understand the redox regulation of p53 in human cells. Thus, a new perspective may 
appear in the redox regulation of p53 gene. 
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ÖZET 
 
ĠNSAN p53 TÜMÖR BASKILAMA GENĠNĠN TĠYOL BAĞIMLI 
OKSĠDOREDÜKTAZLAR ĠLE REGÜLASYONU 
 
Ġnsan tümörlerinin yarısından çoğunda p53 mutasyonlarının görülmesi bu 
proteinin kanseri önlemede önemli bir rolünün olduğunu göstermektedir. Bununla 
birlikte, sistein aminoasitlerine bağlı –SH gruplarının oksidatif koĢullar altında p53 
proteinini inaktif hale getirebildiği bilinmektedir. p53’ün önemli bir tümör süpresör 
olması ve p53 proteininin redoks regülasyonu konusundaki çalıĢmaların yetersizliği bizi 
p53 proteininin redoks regülasyonunu çalıĢmaya yönlendirdi. Bu çalıĢmada maya 
(Saccharomyces cerevisiae) in vivo model olarak kullanılmıĢtır. Mayadaki bütün tiyol-
bağımlı oksidoredüktazlar, yapılarındaki spesifik karakterlerin REDOXCysSearch 
biyoinformatik aracıyla taranmasıyla tespit edilmiĢtir. Ġnsana ait p53 geninin maya 
hücrelerinde çalıĢılabilmesi için, p53 geni ve p53 geni ile uyarılan p53 RE Lac-Z 
raportör sistemi mayalara transforme edilmiĢtir. Antioksidan gen mutantları da LacZ 
raportör gen aktivitesi yönünden incelenmiĢtir. Yabani tip mayaya göre daha düĢük p53 
aktivitesi gösteren bazı maya mutantları tespit edilmiĢtir. Hücre döngüsü regülasyonu ve 
oksidatif stress tolerans mekanizmalasının mayada ve memelilerde korunmuĢ olması 
nedeniyle, maya çalıĢmalarındaki sonuçların memeli hücrelerindeki p53’ün redoks 
regülasyonunu aydınlatmada yardımcı olacağı düĢünülmektedir. Bu sayede, p53’ün 
redoks regülasyonu konusunda yeni bir görüĢ ortaya çıkabilecektir. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1. TP53 Gene and p53 Protein 
 
TP53 gene, which is located on 17p13.1 region of human genome, is one of the 
most important tumor suppressors found in human. It encodes for human p53 protein.  
p53 protein was firstly identified in a complex with large T-antigen in SV40 tumor virus 
transformed cells (Chang, Simmons et al. 1979; Kress, May et al. 1979; Lane and 
Crawford 1979; Linzer and Levine 1979; Melero, Stitt et al. 1979). Then, it was 
characterized as a tumor antigen (Lane and Crawford 1979; Linzer and Levine 1979). 
p53 protein has been given that name because it runs as 53 kilodalton (kDa) protein on 
SDS page. However, actual mass of p53 protein is 43.7 kDa. Due to high amount of 
proline residues in p53 protein, it is observed heavier than it is when it is run on SDS 
page. 
In a normal cell, p53 is found at low levels; however when a cellular stress 
condition like DNA damage, hypoxia, dNTP shortage or absence of telomerase activity 
is induced, p53 protein escapes from proteosome-mediated degradation and it is 
stabilized. Thus, p53 expression becomes much higher under cellular stress (Hainaut 
and Mann 2001; Vousden and Lu 2002). Stabilization of p53 protein initially leads to 
cell cycle arrest and activation of repair mechanisms. If, damage cannot be repaired then 
apoptosis is triggered and cell undergoes death. 
p53 protein mainly functions as a transcription factor. When, p53 is triggered, its 
concentration in the nucleus increase, it specifically binds to DNA and positively or 
negatively affects the activity of many downstream genes. More than 100 genes were 
identified to be regulated by p53 and bioinformatic analysis revealed more than 4000 
potential p53 binding sites in the genome (Lu 2005). p53 does not only fuction as a 
transcription factor but also it binds to several proteins involved in DNA replication, 
transcription and repair. Hence, it mediates certain antiproliferative responses (Ko and 
Prives 1996; Hainaut and Hollstein 2000) . 
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p53 has been one of the most extensively studied tumor suppressor proteins in 
literature. Approximately in 50% of all cancer types, p53 gene itself, is mutated which 
result in accumulation of dysfunctional p53 protein. In the remaining 50% of cancer 
cases, certain abnormalities can exist within the p53 pathway, which in turn attenuates 
its tumor suppressor function (Vogelstein, Lane et al. 2000). This is why p53 is 
important and why it takes the attention of many researchers in cancer biology.  
Key role of p53 in many different cancers led to the development of various p53 
based cancer therapies. However, only one of those therapies was approved for clinical 
usage. This method involves the administration of gene therapy by adenovirus vector 
and this therapy has been used in China since 2003 but not in other countries. On the 
other hand, small inhibitor molecules were developed to inhibit p53-Mdm2 interaction. 
Those molecules were detected to be functional in animal models and now being used 
in clinical trials for treatment of solid and hematologic malignancies. A new method 
called cyclotherapy which uses a p53 activator for protecting normal tissues from 
cytotoxic drugs and which is increasing therapeutic index of treating p53 mutant 
cancers, was shown to be effective in animal models (Cheok, Verma et al. 2011). 
Successful application of those therapies in clinical trials may open a new window in 
the treatment of p53 based cancers.  
 
1.2. Structure of p53 
 
There exist five main domains in p53 structure. They are transcriptional 
transactivation, proline rich, DNA-binding, tetramerization and negative regulation 
domains (Figure 1.1.). Each of those domains has distinct functions. Transactivation 
domain (activation domain I) is mainly responsible for transactivation of many 
proapoptotic genes. Also p53 interacts with many transcription factors like Hdm2 and 
acetyltransferases via its transactivation domain. Proline rich domain is important for 
stability and proapoptotic activity of p53. Between transactivation and proline-rich 
region, there exists activation domain (II) which is responsible for apoptotic activity. 
NLS is signal for nuclear localization of p53 whereas NES is signal for nuclear export 
of the protein. Plus, tetramerization domain plays important role for p53 activity in vivo 
whereas regulatory region is involved in the downregulation of DNA binding. DNA-
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binding domain is the critical region for sequence specific DNA binding (Bai and Zhu 
2006).  
95% of p53 mutations occur in the DNA binding domain and causes loss in 
DNA binding ability of the protein (Vousden and Lu 2002). In addition, Pearson and 
Merill denoted the importance of redox status of cysteines that reside in the DNA 
binding domain. They found out that formation of intramolecular or intermolecular 
disulfide bridges at DNA binding domain could inhibit DNA binding of p53 to target 
region (Pearson and Merrill 1998). 
 
 
Figure 1.1. Domains in p53 protein 
(Source: Bai and Zhu 2006) 
 
1.3. Regulation of p53 
 
Besides the effect of mutations on p53 protein structure, p53 can be regulated 
via many different pathways at transcriptional, post-transcriptional, translational, post-
translational levels. Moreover, p53 function can be controlled by protein-protein 
interactions without modifying its expression status. 
Transcriptional activation of p53 by interferon alpha, beta, gama was discovered 
by Takaoka, Hayakawa et al. Their study identified that interferon induced transcription 
of p53 increased both mRNA and protein levels of p53 and led to increase in apoptosis 
rate (Takaoka, Hayakawa et al. 2003). Moreover, post-transcriptional modifications of 
p53 mRNA has gained importance in p53 regulation. For, instance, U-rich sequence of 
66 nucleotides at the 3’ end of human p53 mRNA was found to be required for 
translational repression of p53. On the other hand, murine p53 was identified to inhibit 
its own translation through binding the 5’ UTR of murine p53 mRNA (Zhang and Chen 
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2008). Furthermore, Mazan-Mamczarz, et.al and Galban et.al showed an enhanced rate 
in translation due to binding of HuR RNA-binding protein to p53 mRNA (Galban, 
Martindale et al. 2003; Mazan-Mamczarz, Galban et al. 2003). p53 can also be 
regulated independent from its expression. This type of regulation is mainly dependent 
on protein-protein interactions. For instance, mdmX proteins directly interact with N-
terminal transactivation domain of p53 and supress its activity without causing 
degradation of p53. In addition, nucleoplasmin binds to N-terminal domain of p53 
protein and represses p53 activity (Maiguel, Jones et al. 2004). 
Advances in understanding post-translational modifications of p53 identified 
many different mechanisms regulating p53 protein at post-translational level. p53 was 
depicted to be subjected to many post-translational modifications like phosphorylation, 
acetylation, methylation, ubiquitination, sumoylation, neddylation, redox regulation, 
etc… Some of these modifications have stabilizing effect on p53 whereas others have 
destabilizing effect. Some modifications may have both stabilizing and destabilizing 
effect depending on the location of the modified residue and also the stimulant in the 
environment (Dai and Gu 2010). 
An array of serine/threonine that reside in the C-terminal regulatory and N-
terminal transactivation domains are subjected to phosphorylation. Phosphorylation can 
either have stabilizing or destablizing effect depending on the residue being 
phosphorylated. For instance, two of the widely studied phosphorylated sites of p53 
protein are S15 and S20 residues in N-terminal transactivation domain. Phosphorylation 
of that site reduces the interaction between p53 and negative regulator of p53. Thus, 
S15/S20 phosphorylation has a positive influence on p53 activity (Toledo and Wahl 
2006). In contrast, S392 hyperphosphorylation was found to be associated with poor 
prognosis, advanced tumor stage and tumor grade in cancer cases that are p53 positive 
(Matsumoto, Furihata et al. 2004; Matsumoto, Furihata et al. 2004; Bar, Slomska et al. 
2009). 
Acetylation is a strong way of activating function. Acetylation has been 
correlated with p53 activation via three different mechanisms. Initially, acetylation 
prevents ubiquitination at the same site and promotes p53 stabilization. Secondly, it 
inhibits HDM2/HDMX repressive complex formation on target promoters and finally 
acetylation is responsible for recruitment of certain cofactors to activate transcriptional 
activation of p53 (Dai and Gu 2010). Nine sites of p53 protein were identified to be 
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critical sites for acetylation. Tissue culture studies indicate the role of acetylation in 
activating, binding of p53 to DNA and transcriptional activity of p53. Thus, acetylation 
provides stability of p53 (Dai and Gu 2010). Acetylation level is balanced by 
deacetylases. For instance, SIRT1, an important protein with deacetylase activity was 
found to play a negative role on p53 activity via deacetylating p53 at K382. Therefore, 
p53 cannot induce its target genes for apoptosis (Luo, Su et al. 2000; Luo, Nikolaev et 
al. 2001). 
There are number of lysine and arginine residues in p53 structure that are 
potential sites for methylation. Methylation may have either positive or negative effect 
on p53 function. For instance, monomethylation of K372 by SET7/9 was found to 
promote transactivation of p53 target genes whereas K382 monomethylation by SET8 
was found to repress p53 transcriptional activity (Chuikov, Kurash et al. 2004; Huang, 
Perez-Burgos et al. 2006; Shi, Kachirskaia et al. 2007). Besides, there exists a 
correlation between repressive and inductive methylation modifications. For example, 
activating methylation of a certain lysine residue may repress repressive methylation of 
another lysine residue. 
One of the most important post-translational modifications that have an effect of 
p53 regulation is ubiquitination. This modification involves the attachment of one or 
more (approximately) 8 kDa ubiquitin molecules to the protein. Monoubiquitination is 
responsible for cytoplamic translocation of p53 and initiates transcription independent 
roles of cytosolic p53 like triggering apoptosis or inhibiting autophagy (Marchenko and 
Moll 2007; Tasdemir, Maiuri et al. 2008; Green and Kroemer 2009). Nevertheless, 
polyubiqutination has a quite different effect on p53 activity. When cell is not under a 
stress condition, p53 levels are low due to Hdm2 activity. Hdm2 ubiquitinates p53 and 
directs it for proteosomal degradation. When there is a damage signal, it inhibits Hdm2 
activity. Thus, p53 can escape from ubiquitination and degradation. By this way, p53 
can be stabilized. Also, a deubiquitinase enzyme HAUSP was found to regulate p53 
pathway by modifying p53, autoubiquitinated Mdm2 and ubiquitinated HDMX 
(Meulmeester, Maurice et al. 2005). 
p53 is subjected to other ubiquitin-like post-translational modifications. 
Sumoylation and neddylation are structurally similar to ubiquitination and conserved in 
eukaryotes. However, they do not have any effect on stability or localization of p53. 
According to literature, sumoylation has been associated with increased transcriptional 
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activity of p53 and premature senescence (Melchior and Hengst 2002; Bischof, 
Schwamborn et al. 2006). In contrast, neddylation was found to inhibit transcriptional 
activity of p53 (Melchior and Hengst 2002; Fomenko 2005). On the other hand, low 
abundance of sumoylation and neddylation of p53 in vivo was associated with a 
challange in vivo. This indiates the importance of those modifications in p53 activity 
(Dai and Gu 2010). 
In addition to all those post-translational modifications discussed above, there 
exist some other mechanisms that play role on p53 activity. Redox state of certain 
cysteine residues in p53 protein has been associated with regulation of p53 through 
disulfide bond formation. Because redox regulation of p53 is the main focus of my 
thesis, studies about this topic will be discussed under another subtitle. 
 
1.4. Redox Regulation of p53 
 
p53 can be regulated through the conserved cysteine residues which function as 
redox sensor. Those critical cysteine residues that reside especially in the DNA-binding 
domain can undergo covalent or oxidative modifications. Those modifications result in 
conformational changes in p53 and affect p53 function. An oxidizing environment can 
cause cysteines in p53 structure to be oxidized and lead p53 to undergo conformational 
changes. Thus, redox modifications influence p53 transcriptional activity and biological 
responses (Stommel, Marchenko et al. 1999). 
Cysteine residues in the DNA binding region can participate in zinc coordination 
or can be regulated by redox regulation. Zinc coordination was shown to be essential in 
p53 function (Hofmann, Moller et al. 2002). Coordination of intrinsic zinc residues with 
cysteines keep p53 in the reduced state and keep its wild type function (Kim, Kundu et 
al. 2011). The rest of cysteines can be induced by oxidizing environment and can be 
modified via redox regulation which involves formation of disulfide bonds, S-
Glutathiolation, nitrosylation, metal binding which alter p53 protein structure and lead 
to inhibition of p53 function. 
There exist many different factors playing role in the redox regulation of p53 
function (Figure 1.2.). Because redox regulation mainly occurs through critical 
cysteines in p53 structure and it is known that formation of intermolecular or 
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intramolecular disulfide bonds inhibit p53 activity, understanding formation of disulfide 
bonds from thiol groups can enlighten the redox regulation of p53. 
 
 
 
Figure 1.2. Factors that have role in redox regulation of p53 
(Source: Kim, Kundu et al. 2011) 
 
1.5. p53 Studies Using Yeast as a Model 
 
Yeast has been an important organism for genetic studies. It has also been used 
in certain p53 studies. Despite not having an internal p53 gene, due to similarities in 
their cell cycle regulation mechanisms, yeast can be used to study human p53 gene. For 
example, the role of PAK1 and TRR1 genes on p53 activity has been determined via 
yeast studies. Thiagalingam, et al showed that PAK1 overexpression in yeast resulted in 
increased DNA binding activity of p53. Due to its structural similarities of PAK1 with 
Ser/Thr specific protein kinases, increase in p53 DNA binding activity was correlated 
with phosphorylation of p53 from its carboxy terminal by Pak1 (Thiagalingam, Kinzler 
et al. 1995). Nevertheless, in 1998, Pearson and Merrill found out the effect of 
thioredoxin reductase on p53 activity. Their system was based on the usage of a p53 
binding site which was followed by a reporter gene. Their study with trr1 gene knock 
out S.cerevisiae, exhibited very low reporter gene activity when compared to wild type 
yeast. The ectopic expression of TRR1 gene complemented the activity loss of p53. The 
interesting thing was there was no change in the protein level of p53 in wild type and 
trr1 knock out yeast. Therefore, they predicted that actity loss of p53 in trr1 knock out 
yeast was sourced from post-translational modification of p53. Because TRR1 functions 
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as a reducing agent for disulfide bridges, they thought that post-translational 
modification of p53 involved thiol oxidation of reduced cysteines (Pearson and Merrill 
1998). Based on the literature, in this study, I would like to understand the effects of all 
known and potential yeast redox proteins, on p53 activity. 
 
1.6. Antioxidant Genes in Yeast 
  
Kinases, phosphatases and thiol dependent oxidoreductases play important 
roles in the regulation of protein activity. There exist two main redox mechanisms, 
thioredoxin and glutathione systems, in two of which NADPH electrons are 
transferred to the target protein. As mentioned in previous sections, cysteine residues 
in certain motifs were identified to be important in those redox mechanisms. 
Especially, CxxC motif has been extensively studied in those systems and detemined 
to reduce intermolecular and intramolecular disulfide bonds. CxxC motif contributes 
to redox regulation by applying the following mechanism. N-terminal cysteine in the 
motif has a decreased pKa and functions as a nucleophilic attacking group in redox 
reactions. This event causes the oxidized cysteine in the substrate to form an 
intermolcular disulfide bond with the enzyme. Then, C-terminal cysteine in the CxxC 
motif, attacks the intermolecular disulfide bond. Thus, disulfide bond forms between 
two cysteines of the redox enzyme and the cyteine on the substrate is reduced 
(Holmgren 1989; Kortemme and Creighton 1995; Martin 1995). In addition to CxxC 
motif, different motifs like CxxS, TxxC, CxxT, SxxC were characterized to serve 
redox activity (Fomenko and Gladyshev 2003). 
Antioxidant genes have significant roles in redox mechanisms. Therefore, 
genome wide identification of antioxidants is important to undestand those 
mechanisms. All oxido-reductive proteins in organisms whose genome is sequenced, 
can be identified based on searching certain redox motifs through bioinformatic 
analysis (Fomenko and Gladyshev 2002; Fomenko and Gladyshev 2003; Fomenko, 
Xing et al. 2007). The list of potential and known redox proteins in yeast, S. 
Cerevisiae, was generated via REDOXCysSearch bioinformatics tool with the help of 
Dr. Fomenko (Fomenko 2005). The algorithm of the bioinformatics tool initially 
searches the CxxS, CxxC, CxxT and SxxC motifs in the protein sequences of yeast 
genome in FASTA format. Then, metal binding proteins are eliminated from the list 
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because they can coordinate with metal ions. Remaining proteins in the list are 
analyzed for conservation through other species. Then, secondary structure of the 
protein is predicted to check the compatibility with the thioredoxin fold motif. Based 
on the structural and biochemical properties of the proteins, 88 proteins were classified 
as anti-oxidant. Some of them are known antioxidants and others have potential to 
function as an anti-oxidant (Fomenko and Gladyshev 2002; Fomenko and Gladyshev 
2003; Fomenko, Xing et al. 2007). All yeast deletion mutants selected via 
REDOXCysSearch software were obtained commercially from EUROSCARF 
organization. All the deletion mutants in the list were analyzed for their role in p53 
regulation previously by Beren Ataç. First analysis of those 88 mutants identified 7 
critical genes with possible antioxidant activities (Atac 2008) . In my thesis, I aimed to 
further characterize those 7 genes for their effect on p53 activity. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
2.1. Plasmids 
 
At the beginning of the study pRS315 RE-Z and pRS316 PGK p53 plasmids 
were used. Those vectors are shuttle vectors which can replicate both in yeast and E. 
coli. In addition, those plasmids are low copy plasmids. 
 
 
Figure 2.1. pRS316 PGK P53 plasmid 
(Source: Atac 2008) 
 
pRS316 PGK p53 plasmid is derived from pRS316 plasmid which includes a 
strong yeast promoter, PGK. This promoter binds to human TP53 gene terminating 
with a yeast terminator. URA3 gene is the auxotrophic marker gene of the plasmid 
(Figure 2.1.). 
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pRS315 RE-Z plasmid is derived from pRS315 plasmid. The modified plasmid 
has a universal p53 binding site called “p53 Response Element” (RE) which is followed 
by Lac-Z reporter gene encoding for β-galactosidase enzyme. LEU2 gene is the 
auxotrophic marker gene of the plasmid (Figure 2.2.). 
 
 
                                  
Figure 2.2. pRS315 RE_Z plasmid 
(Source: Atac 2008) 
       
When both,  pRS315 RE_Z and pRS316 PGK p53, are transformed into yeast, if 
there exists functional p53 protein with DNA binding ability, p53 protein binds to p53 
responsive element on the pRS315 RE_Z . When responsive element is induced via p53, 
β-galactosidase gene could be expressed and activity of reporter gene could be 
analyzed. 
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2.2. Transformation of Plasmids into Yeast via Li-Ac Method 
 
BY4743 (MATα,  ∆his3,  ∆ura3,  ∆met15,  ∆leu2) was used as wild type strain 
to compare p53 activity with deletion mutants. All deletion mutants were derived from 
that strain. 
Transformation of plasmids into yeast cells were carried out by lithium acetate 
method. One loop of yeast cells was transferred from YPD agar plates to 3ml of YPD 
liquid media. Cultures were grown overnight. In the morning, cultures were diluted 
(1/5). Then, cultures were grown at 30 
0
C shaking incubator for 3 more hours. Then 
cells were centrifuged at 5.000 rpm for 5 minutes, pellet was kept and resuspended in 
sterile dH2O and centrifuged again to take the pellet. Then, cell pellet was resuspended 
in 0.1 M LiAc and pelleted by the same process two times. The pellet was resuspended 
in 240 ul 50% PEG, 36 ul 1M LiAc, 25ul salmon sperm single stranded carrier DNA(2 
mg/ml), 5 ul (approximately 500 ng) plasmid and 20 ul 0.3 M DTT. Then, 25ul sterile 
water was added. Suspension was vortexed and incubated at 30 
0
C shaking incubator for 
30 minutes, and then samples were subjected to heat shock at 42 
0
C for 20-25 minutes. 
Transformed cells were spreaded on YNB medium including all the essential amino 
acids required for the growth of transformants. Plates were kept at 30 
0
C for 2-3 days to 
give enough time for the colonies to grow. This transformation protocol was used for 
screening 7 redox gene mutants and their complementation assays. 
 
2.3. β-Galactosidase Assay  
 
After transformed colonies had grown, at least three colonies were selected and 
striken on YNB selection plates. One loop of grown cells was transferred into 5ml 
liquid selective YNB media and culture was grown overnight in 50 ml falcon tubes. In 
the morning, cultures were diluted in 10 ml YNB selective medium and given enough 
time to undergo 2 duplications. Then cells were collected between 0,4-0,6 OD values at 
600 nm wavelength (OD 0,4-0,6 was selected as the optimized interval where the best 
reporter gene activity was observed). Then, 100 ul culture was taken into eppendorfs. 
For each sample, at least 3 replicates were collected. Then, cells were kept on ice to 
immediately begin the assay (Cells were not frozen because analysis with frozen 
samples exhibited decreased reporter gene activity).  
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Z-buffer which includes 60mM Na2HPO4, 2mM NaH2PO4, 10 mM KCl, 1mM 
MgSO4, 50mM β-mercaptoethanol and 0,2% L-Lauryl Sarcosine was prepared. Into all 
eppendorfs which have 100 ul cultures, 400 ul Z buffer and 100 ul YNB selective 
medium was added. Samples were vortexed vigorously. Then, samples were kept at 30 
0
C for 30 minutes via being vortexed every 10 minutes. 4 mg/ml ONPG was prepared 
by dissolving ONPG in Z buffer and 150 ul of that solution was added into each 
eppendorfs and mixtures were vortexed vigorously. Then, samples were incubated at 30 
0
C for 30 minutes. Reaction was stopped by adding 400 ul 1.5M Na2CO3. The mixture 
was pelleted at top speed for 1 minute and 200ul from the supernatant was transferred to 
96-well plate for OD measurement at 420 nm wavelength (Kippert 1995). 
Results were analyzed with respect to absorbance values of cultures at OD 600 
nm and data was normalized according to absorbance values of the wild type sample. 
 
2.4. Gene Cloning for Complementation 
 
 
Figure 2.3. The logic behind gateway system 
(Source: igem 2011) 
 
Candidate genes were cloned into assembly vector, pAG413 GPD, via using 
Gateway Cloning system by Invitrogen. The system is based on two sequential reactions 
called BP and LR (Figure 2.3.). Everything in cloning steps was carried out according to 
manufacturer’s protocol. 
 
2.5. Fusion of Two Plasmids in One Plasmid 
 
During complementation assays, three different plasmids were present together 
in yeast cells (pRS316 PGK p53, pRS315 RE-Z and pAG413 GPD). Because reporter 
system did not work in complementation analysis and yeast cells had great difficulty to 
grow in YNB selective media, it was determined to fuse two plasmids, pRS316 PGK 
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p53, pRS315 RE-Z, in one plasmid. Thus, decreasing the plasmid number in the yeast 
cells was aimed. 
The cases in which three plasmids are present in yeast cells provide limiting 
conditions for cell growth because selective media is very restrictive for growth. Under 
such circumstances, expression of plasmids become problematic. For instance, 
expression of p53 gene is dependent on PGK promoter (promoter for phosphoglycerate 
kinase enzyme) activation. Cell has to be carrying out glycolysis reactions, for PGK to 
be active. Therefore, to examine reporter gene activity correctly, initially restrictive 
conditions should be removed.  For this purpose, fusion of two plasmids to create a 
single plasmid was determined to be done. To do that, initially p53 gene under the 
control of PGK promoter in pRS316 PGK p53 plasmid was amplified via PCR using 
vector specific primers and then cloned into T/A vector (Fermentas) according to 
manufacturer’s protocol. By using Xba1/HindIII sites on the T/A vector, p53 containing 
sequence was seperated from the rest of the plasmid and purified. Then, using the same 
enzymes, Xba1 and HindIII, pRS315 RE-Z plasmid was subjected to restriction. Then 
p53 carrying sequence was tried to be located between the restricted regions of the 
pRS315 RE-Z plasmid. This protocol was repeated many times due to problems in 
ligation of the fragments. At once, fusion of two plasmids in one plasmid was carried 
out successfully (restriction analysis of the newly generated plasmid and the sequence 
analysis of the same plasmid confirmed that plasmid fusion was successful however 
reporter system was not functional. It was thought that observing such a result might be 
normal because both p53 carrying and responsive element including sequences have 
their own promoter and terminator regions in the combined plasmid. In addition, there 
was only 50 bp between two promoter sequences. Therefore, those conditions might be 
inhibiting efficiently expression of the genes. For that reason, another strategy had to be 
developed. 
 
2.6. Integration of Plasmids into the Yeast Genome 
 
Due to expression problems in combined plasmid, a new strategy had to be 
developed. Chromosomal expression of genes was thought to be more stabile when 
compared to expression of genes from plasmids. Therefore, integration of p53 and p53 
RE-Z containing casettes into the yeast genome by using genome integration vectors 
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was performed. Plasmid integration into yeast was based on strategy that was used by 
Sherman, F. (Sherman 1998) and Gietz transformation protocol (Gietz and Woods 
2002) into yeast . 
Initially, p53 and p53 RE-Z had to be integrated into chromosomal integration 
vectors. Because chromosomal integration vectors lack origin of replication, plasmid 
should integrate itself into the genome in order to replicate itself. Because 305 p53 RE-
Z was kindly provided by Gary Merrill, this plasmid was not created by us. At first 305 
p53 RE-Z plasmid sequence was analyzed bioinformatically to find out a rare cutter 
restriction enzyme which only cuts the leu2 gene in the plasmid but does not recognize 
any other sequence in the plasmid. AflII enzyme was determined to be the most suitable 
enzyme for our purpose. Then our first integration vector, 305 p53 RE-Z, was subjected 
to restriction via AflII enzyme. The aim to do restriction was to linearize the plasmid 
because free ends are known to create recombination sites and increase the integration 
efficiency by this way. Basically, to integrate the integration vector to the right place in 
the genome, the vector should have homologous sites to the target region. Thus, 
homologous recombination occurs and integration plasmid can integrate itself into the 
genome. Then linearized plasmid was transformed into W303-1A wild type yeast. 
(Another strain had to be used because BY4741 and BY4743 strains are not compatible 
with genome integration strategy that was required to be used. Those sites lack the 
auxotrophic marker, leu2 gene completely. Therefore, there is no homology site for 
integration to take place). Finally, transformants were seleced in the selective media. 
Next step was the creation of 306-p53 plasmid. For this purpose, p53 gene was 
amplified from pRS316 PGK p53 plasmid via PCR with the help of site specific 
primers. pRS306 vector was subjected to restriction via KpnI and SacI enzymes. Then 
PCR product was ligated with pRS306 vector that was subjected to double digestion. 
Thus, pRS306-p53 plasmid was generated. Then, this plasmid was linearized via BstBI 
enzyme which cuts the ura3 gene in the plasmid approximately from the middle point 
of the sequence. Linearized pRS306-p53 plasmid was transformed into the W303-1A 
transformant which had already been transformed with 305 p53 RE-Z plasmid. Colonies 
were selected on selective media. 
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2.7. Creation of Gene Knock Out in Yeast 
         
 After creation of pRS306-p53 and pRS305 p53 RE-Z containing W303-1A 
transformants, gene knock outs had to be created to continue with the project. To do 
this, a new strategy was developed by using corresponding gene mutants that are in 
BY4741 background. Those knock outs already has the kanmX casette inside. 
Therefore, by using specific primers for approximately 100 bp upsteam and downstream 
regions of the target genes, kanmX casettes and homology arms for the target gene to be 
deleted, were amplified via PCR from BY4741 strain of the corresponding knock out. 
For instance, to delete HNT3 gene from W303-1A+ pRS306-p53+pRS305 p53 RE-Z 
strain, hnt3 knock out of BY4741 was used. To amplify kanmX casette in that mutant, 
primers were designed from nearly 100 bp upstream and downstream regions of HNT3 
gene. Amplified region includes both HNT3 specific homology regions in addition to 
kanmX casette. PCR fragments were transformed based on Gietz transformation 
protocol (Gietz and Woods 2002) and transformants were selected on G418(400 ug/ml) 
containing YPD plates. Due to problems in applied transformation protocol or 
inefficiency of homologous recombination frequency, still certain problems are 
encountered while performing knock out experiments. 
 
2.8. Site Directed Mutagenesis 
 
To understand the basis of redox regulation in mutants with lower LacZ activity, 
critical cysteines in the candidate genes were transformed into serine via site directed 
mutagenesis. For this purpose, Quick-Change II XL site directed mutation kit which is 
commercially available from Agilent Technologies, was used. Working principle of the 
kit is based on PCR reaction with mutation specific primers (Figure 2.4.). Nevertheless, 
primers specific for site directed mutagenesis were designed with the help of a 
bioinformatics tool on web provided by the manufacturer. Each step in the experiment 
was performed according to manufacturer’s protocol. The plasmids which involve site 
directed mutated versions of the critical cysteines in the p53 protein, were kindly 
provided by Gary Merrill. 
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Figure 2.4. The basis of site directed mutagenesis. 
(Source: agilent 2011) 
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CHAPTER 3 
 
RESULTS 
      
Initial screening of 88 different gene mutants indicated a list of 7 genes that 
exhibited significant decrease in reporter gene activity (Atac 2008). Those genes were 
further analyzed for decrease in Lac-Z reporter gene activity. Corresponding yeast gene 
mutants of those candidate genes and wild type control yeast were all transformed with 
pRS316 PGK p53 and pRS315 RE-Z plasmids again, grown for β-galactosidase assay 
and examined for reporter gene activity tests more than 3 times. Figure 3.1.  indicates 
the mutants which exhibited the most significant reporter gene activity decrease when 
compared to wild type control. Those genes are HNT3, MAP1 and SAC1 genes which 
showed approximately 70%, 60% and 50 % decrease respectively in reporter gene 
activity. 
 
 
Figure 3.1. β-galactosidase assay results. Figure indicates the mutants that exhibited the  
                  most significant decrease in reporter gene activity. 
 
After three genes had been selected as the most significant candidates, those 
genes were cloned into pAG413 vector via Gateway Cloning System. Then genes were 
sequenced to confirm whether the genes were cloned successfully. Sequence results 
confirmed that genes were cloned properly (data was not shown here). 
After candidate genes had been cloned, pAG413 vectors carrying those genes 
and pAG413 empty vectors (ponly) were transformed into WT, ∆hnt3, ∆map1 and 
∆sac1 yeast mutants one by one. Figure 3.2. indicates the complementation results. 
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There was no activity in any of the transformants. It was determined that in the presence 
of three plasmids in a yeast cell, reporter system was inhibited.  
 
Transformants B-gal activity 
WT + ponly 0 
WT + HNT3 0 
WT + MAP1 0 
WT + SAC1 0 
∆hnt3 + ponly 0 
∆hnt3 + HNT3 0 
∆map1 + ponly 0 
∆map1 + MAP1 0 
∆sac1 + ponly 0 
∆sac1 + SAC1 0 
 
 Figure 3.2. β-galactosidase assay results for complementations. ponly indicates empty      
                   pAG413 vector. 
 
Problems that were encountered in handling three different plasmids in single 
yeast led the development of a new strategy to overcome the problems. To decrease the 
number of plasmids in the system, 2 plasmids carrying p53 and p53 RE-Z were tried to 
be combined in a single plasmid (see materials and methods section). Despite low 
efficiency in creating combined plasmid, sequence results indicated that combined 
plasmid was successfully created (data was not shown here). Via β-galactosidase assay 
analysis, reporter gene activity in WT yeast transformed with combined plasmid was 
analysed. Activity tests indicated wide variation when compared to the system with two 
plasmids. When the assays were repeated independently, results indicated that there was 
no or very low expression in reporter gene, when it was expressed from the combined 
plasmid (data was not shown here). Lack of reproducible results while using combined 
plasmid, resulted in the development of a new strategy to cope with the problem.  
New strategy was the insertion of p53 and p53 RE-Z cassettes into the yeast 
genome. For this purpose, those cassettes were initially transferred into genome 
integration vectors and then transformed into W303-1A strain one by one (see materials 
and methods section). After both plasmids were inserted into the genome, the 
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transformant was analyzed for reporter gene activity to detect whether reporter system 
is functional when both plasmids are integrated into genome. Figure 3.3. indicates that 
the system is functional. This assay indicated that those integration plasmids integrated 
to the yeast genome properly. However, to confirm whether those plasmids did integrate 
into the correct location in the genome remains unknown until confirmation via PCR. 
For this purpose, site specific primers were designed. However, because those primers 
did not work properly, new primers were ordered and their arrival is expected. For that 
reason, site specific integration of those integration plasmids could not be confirmed via 
PCR. The next step was the creation of hnt3, map1 and sac1 gene knock outs on 
W3031A+305 RE-Z+306-P53 background (see materials and methods section). 
Creation of knock outs with homologous recombination based strategy did not work 
          
 
 
 
Figure 3.3. β-galactosidase results of W303-1A transformed with both of the integration 
                 vectors. 
 
very efficiently. However, two of the knock outs (hnt3 and sac1) were successfully 
created on W3031A+305 RE-Z+306-P53 background (Figure 3.4. , Figure 3.5.). After 
knock out transformants had been selected on G418 plates, genomic DNA isolation was 
performed from certain colonies and knock out positive colonies were confirmed via 
PCR. Figure 3.4. indicates that ∆sac1 colony3 and ∆sac1 colony4 exhibit the same band 
pattern with the PCR product used in the knock out transformation (band size suits 
expected 1922 bp band level), implies that ∆sac1 colony3 and ∆sac1 colony4 are 
positive for SAC1 deletion. 
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Figure 3.4. Creation of ∆sac1on W303-1A+305_REZ+306_p53 background 
 
Figure 3.5 indicates that ∆hnt3 colony1, ∆hnt3 colony2, ∆hnt3 colony4 and 
∆hnt3 colony5 exhibit the same band pattern with the PCR product used in the 
transformation (band size suits expected 1872 bp band level), implies that those 
colonies are positive for HNT3 gene deletion. After creating knock outs, they were 
tested for reporter gene activity. Aim was to confirm whether in the absence of SAC1 
and HNT3 genes in W3031A+305 RE-Z+306-P53 strain, there is decreased reporter 
gene activity compared to wild type control or not. Results showed that there was no  
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Figure 3.5. Creation of ∆hnt3 on W303-1A+305_REZ+306_p53 background 
 
reporter gene activity in knock out yeast whereas in wild type control, there was 
reporter gene activity (data was not shown here). Absence of reporter gene activity in 
knock out yeast could be explained in two ways. i) During creation of knock outs, 
homologous recombination might have affected the reporter sytem integrated into the 
genome and thus inhibit function of reporter system. ii) Removal of SAC1 and HNT3 
genes from the genome may have such a significant effect on p53 activity that, reporter 
gene activity could not be observed. In order to test which explanation is valid, those 
yeast knock outs were complemented by transforming them with genes that they lack. 
Those transformants were subjected to reporter gene activity test. Results indicated that 
there was no reporter gene activity recovery after complementation (data was not shown 
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here). Thus, it was verified that, while creating knock outs, reporter system was 
damaged and became non functional.  
   Rarely, it might be possible that plasmids integrated into the genome can loop 
out and leave the genome. Therefore, knock out yeast on W3031A+305 RE-Z+306-P53 
background, were grown in selective media one by one and their growth patterns were 
examined (Figure 3.6.). Here, only ∆hnt3 colony2 results were shown as an example. In 
figure 3.5. , ∆hnt3 colony2 was shown to be one of the successful knock outs. That 
sample was spreaded on different selective media and its growth pattern was examined 
overnight. ∆hnt3 colony2 was able to grow in the absence of leucine but not in the 
absence of uracil. The result itself proposes that 306-p53 plasmid might have been 
removed while creating knock outs. Interesting thing is that those colonies can grow in 
the medium when both uracil and leucine are absent in the environment. This can be 
explained as in the following. Even if there is a few colonies that have both of the 
plasmids, it can trigger other yeast cells which lack 306-p53 to grow even in the 
selective media.  
 
-leu-ura                    -leu                 -ura 
 
Figure 3.6. Growth pattern of ∆hnt3 colony2 on different selective media 
 
Results indicated that 306-p53 plasmid was less stabile in the genome. 
Therefore, p53 casette was determined to be introduced via pRS414-p53 plasmids into 
the cells which already has 305 RE-Z integrated to their genome. Those transformants 
were checked for reporter gene activity (Figure 3.7.). Results indicated that when 305 
RE-Z plasmid is integrated into W303-1A genome, if p53 is expressed from a plasmid, 
reporter system is functional. Then, reporter system was tested to examine whether a 
second plasmid’s (pAG413) transformation into the system block the reporter gene 
activity or not. Results indicated that addition of the second plasmid to the system did 
not inhibit reporter gene system (data was not shown here). Those results indicated that 
when there is single plasmid integration in the genome, transformation of two different 
plasmids into that yeast does not block the reporter system. Therefore, hnt3, map1, sac1 
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knock outs were determined to be created on W303-1A+305 RE-Z background. Up to 
now, HNT3 gene was successfully removed from the genome (Figure 3.8.).  Figure 
indicates that ∆hnt3 colony1 and ∆hnt3 colony2 are knock outs for HNT3 gene. 
 
              
 Different yeast backgrounds 
 
Figure 3.7. β-galactosidase activity in different transformants. 
 
 
 
 
 
 
                              
 
Figure 3.8. Creation of HNT3 k.outs on W303-1A+305 RE-Z background. 
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After creating hnt3 knock out, it was tested for reporter gene activity. Aim was 
to confirm whether in the absence of HNT3 gene in W3031A+305 RE-Z strain, there is 
decreased reporter gene activity compared to wild type control or not. Results indicated 
a significant decrease in the reporter gene activity in the absence of HNT3 gene (Figure 
3.9.). Further experiments should be done to examine the complementation sytem in 
hnt3 knock out, to create other gene knock outs and to make their reporter system 
analysis. 
 
 
 
Figure 3.9. Reporter gene activity in ∆hnt3 versus WT in W303-1A+305 RE-Z  
                  background. 
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CHAPTER 4 
 
DISCUSSION 
 
In this study, aim was to identify certain thiol-dependent oxidoreductases which 
may be regulating p53 protein activity post-translationally by reducing disulfide bonds 
in the target protein. Yeast, S.cerevisiae was used as a model organism to do the initial 
screening for examining those potential antioxidant genes which were classified so 
based on defined redox motifs in their structure. During the study, reporter gene system 
was used to detect critical antioxidant genes. The system was based on the binding of 
functional p53 protein to the DNA and then inducing the expression of reporter gene, 
LacZ. 
Analysis of reporter gene activity in different potential antioxidant gene mutants 
indicated certain candidate genes which caused significant reduction in the reporter 
gene activity. Repetition of reporter gene activity analysis multiple times indicated the 
most significant potential antioxidant genes as HNT3, MAP1 and SAC1. All of those 
three genes have their human homologs. One of those genes, HNT3 is 5’AMP hydrolase 
which has been associated with DNA repair systems (Daley, Wilson et al. 2010). Yeast 
lacking HNT3 was detected to be more sensitive to DNA damaging agents. In addition, 
HNT3 was found out to be cooperating with Rad27-dependent LP-BER repair of 
oxidative and alkylating damage (Daley, Wilson et al. 2010). Its function in repairing 
oxidative damage may be associated with the antioxidant capability of Hnt3 protein. In 
addition, human homolog of HNT3 gene, aprataxin was found out to have the same 
function with its yeast homolog. Recently, Sykora et al. identified that aprataxin played 
an important role in repair of mtDNA and defects in aprataxin led to mitochondrial 
dysfunction and oxidative stress (Sykora, Croteau et al. 2011). In the absence of 
aprataxin, mitochondrial dysfunction is initiated which is followed by ROS production 
and oxidative stress. Nevertheless, AOA1 patients with mutation in their aprataxin gene 
were identified to have elevated levels of oxidative DNA damage, lower levels of 
CoQ10 which is a potential antioxidant and also AOA1 patients have more genomic 
instability and tendency to develop cancer (Quinzii, Kattah et al. 2005; Le Ber, Dubourg 
et al. 2007). When all new findings are taken into account, aprataxin and its correlation 
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with oxidative stress makes HNT3 gene as a critical gene for antioxidant like function. 
One of the other candidates in our analysis was MAP1 gene which functions as a 
methionine aminopeptidase. MAP1 human homolog is METAP1 gene that is 
structurally similar to METAP2 gene which is an important target of anticancer agents. 
It is known that removal of methionine is important for further amino terminal 
modifications like acetylation, myristoylation etc. In addition, addition of myristate 
residues to proteins predominantly occurs via thioester bond formation (Selvakumar, 
Lakshmikuttyamma et al. 2006). Due to their effects on modifying target proteins on 
their thiol groups, METAPs may also have oxidoreductase function revealing MAP1 as 
a good candidate for antioxidant activity. The last candidate according to our analysis is 
SAC1, which is known to function as phosphoinositide phosphatase. Studies with 
mammalian SAC1 revealed the importance of SAC1 especially in golgi organization. In 
addition, SAC1 was identified to work as a tumor suppressor (Liu, Boukhelifa et al. 
2009). However, because it is known that SAC1 is a phosphoinositide phosphatase, it is 
most likely that it can contribute post-translational modifications as a phosphatase 
instead of working like a thiol dependent oxidoreductease. Therefore, based on known 
function of SAC1, it does not seem to be a good candidate as an antioxidant. However, 
because some of the proteins may have multiple functions, SAC1 gene also needs to be 
further analyzed. 
Results presented here indicate the decrease in the p53 transactivation activity in 
the absence of certain potential antioxidant genes. However, those results do not 
indicate anything about the mechanism of the transactivation decrease or the inhibition 
mechanism is redox dependent or not. Therefore, based on the current data, it is not 
possible to propose whether p53 transactivation decrease is dependent on redox 
mechanism or an outcome of disruption in protein-protein interactions or any another 
type of regulation. In addition, absence of those genes may have an influence on one of 
the upstream regulators of p53 which causes a decrease in p53 transactivation 
capability. Also, a different post-translational mechanism rather than redox regulation 
may have an effect on decrease in p53 transactivation. For instance, in the case of 
SAC1, mechanism can be correlated with phosphorylation/dephosphorylation process of 
p53. On the other hand, using yeast as a model organism can be limiting the interactions 
between p53 and its upstream regulators. In addition, yeast is known to lack certain 
post-translational modifications found in higher eukaryotes, lack of those post-
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translational modifications in upstream regulators of p53 may be inhibiting 
transactivation activity of p53.  
It is possible enlighten the potential redox mechanism behind candidate genes 
through an appropriate experimental design. Initially, after creation of all the knock outs 
on W303-1A+305 RE-Z background, those gene mutants should be transformed with 
p53 including plasmid and reporter gene activity in them should be measured and 
compared with wild type control to confirm whether there is decrease in transactivation 
of p53 in gene mutants derived from W303-1A+305 RE-Z strain. If decreased reporter 
gene activity can be observed, those gene mutants should be complemented with the 
genes they lack to understand whether regain of the gene recovers decreased 
transactivation activity of p53. Then, the reporter gene activity should be tested by 
transforming yeast mutants with antioxidant genes and p53 whose cysteines were 
transformed into serines, the closest amino acid to cysteine. In the absence of cysteines 
in p53, stability of p53 protein is expected to be increased via eliminating oxidation 
sites. In contrast, in the absence of cysteines in potential antioxidant genes, p53 stability 
is expected to decrease due to inhibition in thiol-dependent oxidoreductase activity of 
the antioxidant gene on p53. In addition, to confirm that decrease in reporter gene 
activity is not dependent on change in the protein level of p53 but due to post-
translational modification on p53, western blotting should be carried out. Finally, 
repetition of those experiments in reducing and non-reducing conditions at the same 
time, may give more idea about the redox regulation mechanism. Those experiments 
above can enlighten whether p53 activity decrease in this system is a redox-dependent 
mechanism or not.  
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CHAPTER 5 
 
CONCLUSION 
 
In conclusion, 7 antioxidant gene mutants of yeast were further analyzed for p53 
transactivation activity and three of them (∆hnt3, ∆map1, ∆sac1) were shown to exhibit 
the most significant decrease in p53 activity when compared to wild type yeast. 
Especially, HNT3 gene which is homologous gene for human aprataxin is predicted to 
be a strong candidate for having a thiol-dependent oxidoreductase activity. Whether the 
p53 transactivation decrease was dependent on redox regulation of the protein or not 
could not be determined based on the results. However, complementation assays 
followed by analysis of Cys→Ser mutations may open a new perpective in the 
regulation of p53 protein by thiol-dependent oxidoreductases. 
 
5.1. Future Perpectives 
 
Using yeast, S.cerevisiae to study human p53 gene may be advantageous to 
perform an initial functional screening of potential antioxidant genes. However, data 
proposed here should be examined in different mammalian cell lines, to understand that 
mammalian homologs of those genes also have exactly the same function as their yeast 
homologs. Because, yeast cells lack certain post-translational modifications and some of 
the upstream regulators of p53, transactivation ability of p53 may change when the 
same reporter system of yeast is examined in the mammalian cell lines. 
In clinical studies, DNA damaging agents have been widely used. 
Understanding of redox regulation of target genes in the cancer related pathways may 
lead the appearance of new perspectives in clinics. If importance of redox regulation of 
target proteins could be clearly identified, tissue specific application of certain thiol-
dependent oxidoreductases may become a valuable therapy for treating many of the 
redox dependent cancers, in the future. 
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APPENDIX A 
 
PROTOCOLS 
 
Plasmid Isolation from E. coli 
1. For plasmid isolation from E.coli at low and large scale, PureLink™ Quick 
Plasmid Miniprep Kit and PureLink™ HiPure Plasmid Filter Midiprep Kit that are 
commercially available from Invitrogen were used respectively. All experimental steps 
were carried out based on manufacturer’s recommendations. 
 
Plasmid Transformation into E. coli 
 
E.coli competent cells were defrosted on ice for 10 minutes. Then, 
approximately 200 ng plasmid was added into competent cells and mixture was kept on 
ice for 20 more minutes. Mixture was subjected to heat shock (42 
0
C) for 40 seconds 
and then kept on ice for 2 minutes. Then, 250 ul SOC medium is added to mixture and 
mixture is kept in a shaking incubator (37 
0
C) incubator for 1 hour. Mixture is spinned 
down and supernatant is removed then cell pellet is resuspended in 150 ul sterile water 
and spreaded on LB agar plate which includes selective antibiotic. Plate is kept at 37 
0
C 
overnight for colonies to grow. 
 
PCR Reaction for Cloning Genes 
 
1 ul BY4741 genomic DNA 
5 ul HF buffer with MgCl2 
5 ul DNTP mix 
0.5 ul forward primer (10 pmol) 
0.5 ul reverse primer (10 pmol) 
0.5 ul HF enzyme commercially available from Fermentas 
37.5 ul UP water 
PCR reactions were carried out by taking optimum temperature for primer 
annealing and gene product size into account. 35 PCR cycles are performed. 
 
 
Agarose Gel Electrophoresis and Gel Extraction of PCR product 
 
50 ul 1X TAE buffer 
0.5 gr agarose 
EtBr 
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2. All PCR products are loaded on gel and run at 100 volts for 1 hour. Then, 
PCR product at appropriate level is cut and subjected to gel extraction via Fermentas 
Silica Bead DNA Gel Extraction Kit according to manufacturer’s 
recommendations. 
 
Linearization of Genome Integration Plasmids, Plasmid Digestion 
 
20 ul plasmid DNA (isolated via midiprep, approximately 40 ug) 
15 ul UP water 
15 ul appropriate enzyme buffer 
3.5 ul appropriate restriction enzyme 
0.2 ul DTT 
Restriction reaction was kept at appropriate temperature for 3.5 hours and then 
reaction was stopped via heat inactivation. 
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APPENDIX B 
 
PRIMERS 
 
Primers for Gene Deletion 
 
HNT3A:CTTACATCTTGCCCAAGGATGCAC 
HNT3B:CGTGATCACATCAACCCTGATGA 
MAP1A:TCATCCCAAGAACGCTATTGTGT 
MAP1B:GCTTCTCATAATAACCAATTCGGAC 
SAC1A:CTGCACTACTGCTTACCCACACTAC 
SAC1B:ATAGCTTGTTCTTCCCTCTGGG 
 
Primers for Site Directed Mutagenesis  
 
primer name primer sequence 
  
SAC1 C392S      cattccgttgtaagaacaaacagtatggattgtttggacagaa 
SAC1 C392SB  ttctgtccaaacaatccatactgtttgttcttacaacggaatg 
SAC1 C395S     gtaagaacaaactgtatggatagtttggacagaacaaatgtcg 
SAC1 C395SB   cgacatttgttctgtccaaactatccatacagtttgttcttac 
MAP1C37S gagaaacttcgtcccaaatgaaaagccctgtttgtc 
MAP1C37SB gacaaacagggcttttcatttgggacgaagtttctc 
MAP1C40S cccaaatgaaatgccctgttagtctaaaacaaggcatc 
MAP1C40SB gatgccttgttttagactaacagggcatttcatttggg 
HNT3C188S acctgaaagaacacgatttacttagctgctattgtcagc 
HNT3C188SB Gctgacaatagcagctaagtaaatcgtgttctttcaggt 
HNT3C189S   gaaagaacacgatttactttgcagctattgtcagcgaaattttag 
HNT3C189SB ctaaaatttcgctgacaatagctgcaaagtaaatcgtgttctttc 
HNT3C191S gaacacgatttactttgctgctatagtcagcgaaattttagtaataaa 
HNT3C191SB tttattactaaaatttcgctgactatagcagcaaagtaaatcgtgttc 
 
 
